At StemBioSys, Inc. we are committed to providing research tools that facilitate and enhance in vitro research, tissue modeling, drug development and diagnostics.

At StemBioSys, Inc. we are committed to providing research tools that facilitate and enhance in vitro research, tissue modeling, drug development and diagnostics.

At StemBioSys, Inc. we are committed to providing research tools that facilitate and enhance in vitro research, tissue modeling, drug development and diagnostics.

During the COVID–19 pandemic (caused by the coronavirus SARS-CoV-2) we have been working with a reduced staff in our research laboratory and manufacturing facility to maintain our current research tool products inventory needed to meet our current customer’s needs. Additionally, we have been busy working with various researchers and partners on grant applications directed at the development of in vitro tissue models.

StemBioSys launches CELLvo™ Human Articular Chondrocytes, low passage cells for highly relevant cartilage research

Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or upon a single passage and expansion on CELLvo™ Matrix.